- Dr. Bishal Gyawali achieved a rare promotion to Full Professor of Oncology at Queen’s University only eight years after starting his Canadian fellowship.
- He advocates for "Common Sense Oncology" and "Cancer Groundshot," prioritizing affordable, effective treatments over expensive drugs with marginal benefits.
- A global authority, Dr. Gyawali advises the WHO and the Canadian government on drug pricing and essential cancer medications.
Kingston, Ontario, Canada/Kathmandu, Nepal: It was exactly eight years ago that Dr. Bishal Gyawali arrived in Canada as a medical fellow, eager to learn but stepping into an entirely new healthcare system. Today, he officially stepped into his office at Queen’s University with a new title: Full Professor of Oncology.
In the world of academic medicine, climbing from a fellow to a full professor usually takes decades. Doing it in eight years is a meteoric, almost unheard-of achievement. But for those who know Dr. Gyawali, the milestone is simply the latest chapter in a life driven by a deeply personal mission: making cancer care fairer, more logical, and deeply human.
Marking the moment publicly, Dr. Gyawali was quick to deflect the spotlight from his own achievements to the people who walked the path with him.
"This has been quite an incredible journey from being a fellow to a professor in 8 years," Dr. Gyawali shared. "I’m very grateful to everyone who has unwaveringly supported me throughout this, specially my incredible family, friends, mentors, mentees, colleagues, collaborators, and patients. Thank you Queen’s University and Department of Oncology for this honour and recognition through promotion. It means a lot."
From Nepal to Kingston: A Journey Across Continents
Dr. Gyawali's perspective on medicine was shaped long before he arrived in Kingston. Growing up in Nepal, he saw firsthand what happens when life-saving medical care is a luxury few can afford. Driven to make a difference, he completed his MBBS at Tribhuvan University's Institute of Medicine, graduating first out of 15,000 applicants and sweeping seven gold medals.
His thirst for knowledge took him to Japan, where he earned a PhD in medical oncology, and later to Boston, where he studied cancer policy at Harvard. When he finally landed at the Cancer Centre of Southeastern Ontario in 2019, he brought with him a global view of healthcare—and a burning question: Are we actually helping the patient in front of us?
Within just two years of arriving at Queen's, his clinical insight and research saw him appointed as an Associate Professor of Oncology and Public Health Sciences, setting the stage for his record-paced promotion to full professor.
The Doctor Who Championed "Common Sense"
While Dr. Gyawali spends his weeks treating patients with breast, gastrointestinal, and genitourinary cancers at Kingston General Hospital, he has spent his nights becoming a leading global voice against the skyrocketing costs of cancer drugs.
He noticed a troubling trend in modern medicine: pharmaceutical companies celebrating expensive new drugs that only extended a patient’s life by a few weeks on paper, while often causing severe side effects and financial ruin in reality.
To fight this, he co-founded "Common Sense Oncology," a global movement that asks a simple but radical question: Does this treatment actually make the patient live longer, or live better? If the answer is no, Dr. Gyawali argues, the medical community needs to rethink its priorities.
He also famously coined the term "Cancer Groundshot." While world leaders love to fund multi-billion-dollar "moonshots" to find flashy, high-tech cures, Dr. Gyawali argues that we would save millions more lives right now by simply getting the affordable, proven cancer drugs we already have into the hands of patients who can't access them—especially in low-income countries.
A Global Impact from a Canadian Home
Today, Dr. Gyawali’s work bridges the local community in Kingston with the highest levels of global health policy. He is a trusted advisor to the World Health Organization (WHO), helping decide which cancer medicines are essential for humanity, and he advises the Canadian government on drug pricing.
Yet, despite his 200+ published papers in journals like The Lancet Oncology and the New England Journal of Medicine, colleagues and patients know him best for his humility, his dedication to teaching, and his unwavering belief that a doctor's primary job is to care for the human being, not just treat the disease.
For Queen’s University, promoting Dr. Gyawali isn't just about recognizing a brilliant researcher; it’s about honoring a physician who is actively trying to bring the heart back into cancer care.
